HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticoagulation in patients with valvular heart disease, atrial fibrillation, or both.

Abstract
Despite the availability of anticoagulant drugs for many years, there are still controversies regarding their use in many cardiovascular conditions. In this article, the pharmacology of warfarin and heparin are reviewed, and the clinical applications of these therapies in patients with valvular heart disease, atrial fibrillation, or both, discussed.
AuthorsS L Kadish, E J Lazar, W H Frishman
JournalCardiology clinics (Cardiol Clin) Vol. 5 Issue 4 Pg. 591-628 (Nov 1987) ISSN: 0733-8651 [Print] Netherlands
PMID3331319 (Publication Type: Journal Article, Review)
Chemical References
  • Warfarin
  • Heparin
Topics
  • Atrial Fibrillation (drug therapy)
  • Bioprosthesis
  • Heart Valve Diseases (drug therapy)
  • Heart Valve Prosthesis
  • Heparin (therapeutic use)
  • Humans
  • Risk Factors
  • Thromboembolism (prevention & control)
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: